Literature DB >> 22644489

SHP-2 and PTP-pest induction during Rb-E2F associated apoptosis.

Liza D Morales1, Karina Pena, Dae Joon Kim, Jonathan H Lieman.   

Abstract

Apoptosis is intimately connected to cell cycle regulation via the Retinoblastoma (Rb)-E2F pathway and thereby serves an essential role in tumor suppression by eliminating aberrant hyperproliferative cells. Upon loss of Rb activity, an apoptotic response can be elicited through both p53-dependent and p53-independent mechanisms. While much of this apoptotic response has been attributed to the p19ARF/p53 pathway, increasing evidence has supported the role of protein tyrosine phosphatases (PTPs) in contributing to the initiation of the Rb-E2F-associated apoptotic response. One protein tyrosine phosphatase, PTP-1B, which is induced by the Rb-E2F pathway, has been shown to contribute to a p53-independent apoptotic pathway by inactivating focal adhesion kinase. This report identifies two additional PTPs, SHP-2 and PTP-PEST, that are also directly activated by the Rb-E2F pathway and which can contribute to signal transduction during p53-independent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644489      PMCID: PMC6275625          DOI: 10.2478/s11658-012-0020-9

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  3 in total

Review 1.  To live or let die - complexity within the E2F1 pathway.

Authors:  A Poppy Roworth; Fatemeh Ghari; Nicholas B La Thangue
Journal:  Mol Cell Oncol       Date:  2015-01-30

2.  Protein tyrosine phosphatases PTP-1B, SHP-2, and PTEN facilitate Rb/E2F-associated apoptotic signaling.

Authors:  Liza D Morales; Edgar A Casillas Pavón; Jun Wan Shin; Alexander Garcia; Mario Capetillo; Dae Joon Kim; Jonathan H Lieman
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

3.  Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.

Authors:  Man-Gang Lee; Yi-Chang Liu; Yi-Lun Lee; Mohamed El-Shazly; Kuei-Hung Lai; Shou-Ping Shih; Seng-Chung Ke; Ming-Chang Hong; Ying-Chi Du; Juan-Cheng Yang; Ping-Jyun Sung; Zhi-Hong Wen; Mei-Chin Lu
Journal:  Mar Drugs       Date:  2018-06-10       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.